Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
Fast and simple method for preparing amplified cDNA from FFPE-derived total RNA
***************************************************************************************
***************************************************************************************
Tab 01 / Overview
***************************************************************************************
***************************************************************************************
The Ovation® FFPE WTA System provides a fast and simple method for preparing amplified cDNA from FFPE-derived total RNA.
Amplification is initiated at the 3´ end as well as randomly throughout the whole transcriptome in the sample, making this system ideal for amplification of the severely degraded and chemically modified RNA typically obtained from FFPE samples.
The Ovation® FFPE WTA System is powered by SPIA® technology, a novel and sensitive RNA amplification process developed by Tecan.
Tecan has been a valued partner in the development and commercialization of Afirma® Thyroid FNA Analysis. Tecan’s sample preparation technology is a critical component in addressing the challenges of extracting genomic information from small, fine needle aspirate biopsies. Their dependable supply, quality and excellent customer service provides us with the assurance we need in pioneering the development of novel molecular diagnostic tests.
***************************************************************************************
***************************************************************************************
Tab 02 / Highlights
***************************************************************************************
***************************************************************************************
Graph above shows data from Forty-one FFPE-derived ovarian tumor samples. A minimum of 5.8 μg is required for analysis on GeneChip arrays (shown by the red bar) a criteria met by all amplifications in this study.
Targets were prepared from RNA extracted from formalin-fixed, paraffin-embedded tissue (FFPE) from one donor (red) and fresh frozen tissue from a second donor (blue). Each sample was amplified in quadruplicate and hybridized to Affymetrix HG-U133A 2.0 GeneChip arrays. PCA was performed using Partek Genomics Suite software. The green and blue ellipses (NAT and Tumor, respectively) define the boundary of 2 standard deviations from the centroid of each cluster indicating a statistically significant separation of samples based on the disease state of the tissue. This demonstrates that the amplification system maintains the integrity of the biological data.
***************************************************************************************
***************************************************************************************
Tab 03 / Specifications
***************************************************************************************
***************************************************************************************
Specification |
Specification/Description |
---|---|
Compatible Platform |
Compatible Platform Affymetrix GeneChip Arrays, Illumina BeadChips, Agilent Dual Mode Array |
Amplification Type |
Amplification Type Whole transcriptome |
Starting Material |
Starting Material Total RNA derived from FFPE tissue |
Input Amounts |
Input Amounts 50 – 100 ng |
***************************************************************************************
***************************************************************************************
Tab 04 / Faq
***************************************************************************************
***************************************************************************************
The Ovation FFPE WTA System provides all necessary buffers, primers and enzymes for first strand synthesis, second strand synthesis and amplification. The kit also provides Nuclease-free Water and Agencourt Beads for double-stranded cDNA purification. Beads are not provided for the final purification step.
No. This system is used to generate SPIA cDNA from FFPE RNA samples. The SPIA cDNA may be processed further using a Tecan Encore labeling module or other supported labeling protocol.
Required equipment includes a microcentrifuge, pipettes, vortexer, a thermal cycler, a spectrophotometer and a magnetic plate for 0.2 mL tubes, strips, or plates. An Agilent Bioanalyzer or Fragment Analyzer may also be useful for optional analytical tests.
For the SPIA cDNA purification step, purification columns or SPRI beads are required. Refer to the Appendix in the User Guide for validated purification products and procedures.
In this system, oligo dT primers are mixed with random primers for the first strand synthesis of cDNA products. This allows amplification coverage of the whole transcript. We have tested the system with both degraded and intact RNA on 3´ microarray designs as well as arrays interrogating sequence in all regions of the transcript (i.e., Thermo Fisher Scientific (formerly Affymetrix) GeneChip arrays) with successful results.
Yes. Amplified cDNA may be stored at –20 °C for at least six months.
We recommend a column-based method, including:
Organic methods such as TRIzol® Reagent should be subsequently followed with a column-based clean-up method.
We do not recommend the use of TRIzol or similar methods as any carryover of organic solvents may inhibit downstream enzyme activity. If using TRIzol extracted RNA, we recommend using a column-based purification of the RNA prior to input into the kit.
We do not recommend the use of carriers during RNA isolation. If a carrier is required, please contact Tecan NGS Technical Support for more information.
No. The Ovation FFPE WTA System employs a whole transcriptome amplification approach and was designed specifically for use with highly degraded, lower quality RNA samples.
Yes. While the Ovation FFPE WTA System was developed specifically for use with total RNA from FFPE samples, it is possible to use intact, non-FFPE RNA samples as well. Performance with intact total RNA samples below 2 ng may vary.
We recommend total FFPE RNA inputs in the range of 50 to 100 ng. Input amounts outside this range may produce unsatisfactory variable results, especially for more degraded RNA.
No. The Ovation FFPE WTA System is designed to amplify RNA, not DNA.
Yes. This system is designed to amplify RNA, but contaminating genomic DNA may amplify during the process. For this reason we recommend DNase treatment during RNA purification.
The Ribo-SPIA amplification process may work with some bacterial RNAs. However, the kit has not been optimized or validated for this purpose.
No. The DNA/RNA primers provided in the Ovation FFPE WTA System are universal.
RNAClean XP beads are certified to be RNase and DNase free. We have tested both RNAClean XP and AMPure XP beads in our kits and observe no difference in performance between products.
Due to the large number of commercially available magnets, we do not have a comprehensive list of compatible products. However, many magnets are compatible. As long as the magnet is strong enough to clear the solution of magnetic beads, it can be applied to the system. We have the following guidelines for selecting a magnetic separation device:
You should expect 4 to 7 μg of cDNA from 50 to 100 ng total FFPE RNA starting material, if it is of sufficient quality. Yields may be higher using intact, non-FFPE RNA samples. Although yield is an important sample quality indicator, success of a given FFPE sample set in array analysis is best predicted using the RNA Sample Quality Assessment Tool described in the WT-Ovation FFPE System RNA Sample Quality Assessment technical report.
The amplified cDNA size distribution can vary based on the input RNA integrity. In a whole transcriptome amplification strategy, however, the size of the resulting cDNA is not of significant consequence for use on arrays.
Yes. Although this is not absolutely necessary, it is important to be able to quantify the SPIA cDNA. This allows assessment of amplification success based on the amplification yields. It also allows mass normalization of the cDNA into qPCR.
The number of qPCR reactions depends on the abundance level of the genes being interrogated. For medium- to high-copy genes, the cDNA may be diluted as much as 400-fold, enough for thousands of qPCR reactions. For very-low-copy genes more cDNA must be used per qPCR reaction. We recommend purification of the amplified cDNA prior to qPCR analysis.
***************************************************************************************
***************************************************************************************
Tab 05 / Literature
***************************************************************************************
***************************************************************************************
Provides a rapid, simple and easily automatable approach for fragmentation and labeling...
For research use only. Not for use in diagnostic procedures.